With a Greek referendum scheduled for Sunday, there could be more upsets Read More

Some developed economies are also at risk, threatening income investors Read More

GlaxoSmithKline (NYSE: GSK) will sell its over-the-counter business to Ireland-based Perrigo to fulfill its regulatory obligations following its $20 billion-plus asset swap with Novartis. The 10-product portfolio, known as GlaxoSmithKline Consumer Healthcare, generated sales of about $110 million in 2014.As GSK undergoes this transition to refocus its vaccines business, the… Read More

This REIT’s strong leadership and portfolio growth produce a stable, rising dividend.  Read More

Offering both income and upside potential, convertible stocks have many of the same protections as preferred shares. Read More

They’re a dynamic group with varied backgrounds but one common thread: results. Read More

Global Income Edge applies its Early Warning System to its portfolio companies. Read More

Bank regulators are making waves, but the system is  healthy. Read More

Real Estate Investment Trusts preserve value when rates rise. Read More

Our holdings, AT&T and Verizon, are positioned perfectly. Read More